Incyte Corp (NASDAQ:INCY)

98.28
Delayed Data
As of May 01
 +1.12 / +1.15%
Today’s Change
43.86
Today|||52-Week Range
111.93
+34.43%
Year-to-Date

Today’s Trading

Previous close97.16
Today’s open98.86
Day’s range96.83 - 101.00
Volume1,622,154
Average volume (3 months)1,232,153
Market cap$17.6B
Dividend yield--
Data as of 3:59pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+13.58%
Earnings growth (next 5 years)+209.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+3.87+3.45%
PCYCPharmacyclics Inc-1.69-0.66%
ENDPEndo International P...+0.98+1.17%
HSPHospira Inc0.000.00%
Data as of 4:14pm ET, 05/01/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers